Optio Biopharma Solutions, LLC
  • Home
  • About Us
  • Services
  • Team
  • Cases
  • News
  • Contact
Surmounting market challenges and exceeding client objectives since 2007.
Optio Biopharma Solutions, LLC
  • Home
  • About Us
  • Services
  • Team
  • Cases
  • News
  • Contact
Office (650) 308 4999
HomeNews
Eric Miller appointed as Executive Director of global rare disease advocacy group – March 2020
March 9, 2020
Optio attends CHDI – February 2020, Palm Springs, USA
February 27, 2020
Optio attends the Huntington Study Group annual meeting – November 2019, Sacramento, CA
November 27, 2019
JP Morgan Healthcare Conference, January 2019; Optio Biopharma Solutions conducts neurodegenerative rare disease asset valuation due diligence and other activities
January 15, 2019
The Huntington’s market heats up – observations as Optio attends the November 2018 HSG congress.
November 11, 2018
Optio attends Huntington’s Disease Society of America 33rd annual convention – Los Angeles, June 2018
June 6, 2018
Optio welcomes Ebo Dawson-Andoh; Executive Consultant, Pharma/Healthcare Survey Analyst – January 2018
January 15, 2018
Optio conducts social worker and caregiver focus group research at a neurological rare disease meeting – Chicago, IL.
June 21, 2017
Optio conducts business development interviews for a rare disease product valuation in conjunction with the 35th Annual J.P. Morgan Healthcare Conference.
January 9, 2017
Optio Biopharma Solutions attends the 23rd Annual Huntington’s Study Group Meeting and 10th Annual Clinical Research Symposium in Nashville, TN.
November 2, 2016

Tweets by OptioBiopharma

All new engagements start with a meeting.

Let's Meet!
Optio Biopharma Solutions, LLC
Tweets by OptioBiopharma

Recent News

  • Eric Miller appointed as Executive Director of global rare disease advocacy group – March 2020
  • Optio attends CHDI – February 2020, Palm Springs, USA
  • Optio attends the Huntington Study Group annual meeting – November 2019, Sacramento, CA

Subscribe

* indicates required
© 2017 Optio Biopharma Solutions, LLC. All Rights Reserved.